Nexalin Technology (NXL) Competitors $0.96 -0.02 (-2.35%) Closing price 07/3/2025 03:39 PM EasternExtended Trading$0.96 0.00 (0.00%) As of 07/3/2025 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. TELA, EDAP, MLSS, MDAI, SURG, HYPR, NEPH, ICCM, APT, and CTCXShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include TELA Bio (TELA), Edap Tms (EDAP), Milestone Scientific (MLSS), Spectral AI (MDAI), SurgePays (SURG), Hyperfine (HYPR), Nephros (NEPH), IceCure Medical (ICCM), Alpha Pro Tech (APT), and Carmell (CTCX). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Its Competitors TELA Bio Edap Tms Milestone Scientific Spectral AI SurgePays Hyperfine Nephros IceCure Medical Alpha Pro Tech Carmell TELA Bio (NASDAQ:TELA) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability. Is TELA or NXL more profitable? TELA Bio has a net margin of -61.00% compared to Nexalin Technology's net margin of -6,529.77%. Nexalin Technology's return on equity of -277.92% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-61.00% -402.45% -62.73% Nexalin Technology -6,529.77%-277.92%-245.37% Do insiders & institutionals have more ownership in TELA or NXL? 94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by insiders. Comparatively, 25.3% of Nexalin Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, TELA or NXL? TELA Bio has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.7, meaning that its stock price is 270% more volatile than the S&P 500. Which has better earnings & valuation, TELA or NXL? Nexalin Technology has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M1.18-$37.84M-$1.41-1.47Nexalin Technology$131.07K125.43-$7.61M-$0.83-1.15 Do analysts recommend TELA or NXL? TELA Bio currently has a consensus target price of $7.25, indicating a potential upside of 249.40%. Nexalin Technology has a consensus target price of $5.00, indicating a potential upside of 422.47%. Given Nexalin Technology's stronger consensus rating and higher probable upside, analysts clearly believe Nexalin Technology is more favorable than TELA Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to TELA or NXL? In the previous week, TELA Bio and TELA Bio both had 1 articles in the media. Nexalin Technology's average media sentiment score of 0.75 beat TELA Bio's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nexalin Technology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNexalin Technology beats TELA Bio on 10 of the 15 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$16.83M$2.37B$12.98B$8.95BDividend YieldN/A1.34%2.57%4.09%P/E Ratio-1.1531.4428.6620.24Price / Sales125.4336.3242.41125.07Price / CashN/A40.7025.6857.47Price / Book3.425.876.275.67Net Income-$7.61M$32.32M$187.50M$248.47M7 Day Performance4.02%5.99%3.54%3.29%1 Month Performance-22.82%7.19%4.13%5.18%1 Year Performance-31.64%32.79%27.93%21.35% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology2.3698 of 5 stars$0.96-2.3%$5.00+422.5%-31.6%$16.83M$131.07K-1.153Gap DownTELATELA Bio2.6084 of 5 stars$1.73+4.8%$7.25+319.1%-52.3%$65.27M$71.22M-1.23120Gap UpEDAPEdap Tms2.4378 of 5 stars$1.72+1.3%$8.50+394.2%-69.6%$63.49M$69.18M-2.77230MLSSMilestone Scientific2.9918 of 5 stars$0.80-9.1%$1.25+56.4%+1.5%$62.70M$8.61M-11.4130Gap UpMDAISpectral AI3.0412 of 5 stars$2.05-6.4%$4.75+131.7%+44.7%$55.44M$29.58M-3.8083Analyst RevisionGap UpSURGSurgePays3.2209 of 5 stars$2.73+1.1%$9.00+229.7%+10.8%$55.11M$60.88M-0.9840HYPRHyperfine1.9181 of 5 stars$0.690.0%$1.06+52.8%-23.4%$54M$12.89M-1.28190Gap DownNEPHNephros0.8948 of 5 stars$4.29-14.2%$5.00+16.6%+96.6%$53M$14.16M61.2930News CoveragePositive NewsGap DownHigh Trading VolumeICCMIceCure Medical2.1497 of 5 stars$0.92-3.3%$2.50+171.7%+43.2%$52.79M$3.29M-3.2960News CoverageAPTAlpha Pro Tech1.6637 of 5 stars$4.76+0.2%N/A-16.1%$51.71M$58.18M12.86120CTCXCarmellN/A$2.41-2.4%N/A+40.8%$50.38M$32.84K0.0014News CoverageGap Down Related Companies and Tools Related Companies TELA Bio Alternatives Edap Tms Alternatives Milestone Scientific Alternatives Spectral AI Alternatives SurgePays Alternatives Hyperfine Alternatives Nephros Alternatives IceCure Medical Alternatives Alpha Pro Tech Alternatives Carmell Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXL Stock Alerts